Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPPI
2351
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $2.51M | ﹤0.01% |
689,634
+14,458
| +2% | +$117K |
|
|
LORL
2352
DELISTED
Loral Space and Communications, Inc.
LORL
| $2.5M | ﹤0.01% |
77,447
+1,696
| +2% | +$62.2K |
|
|
AMAG
2353
DELISTED
AMAG Pharmaceuticals
AMAG
| $2.5M | ﹤0.01% |
205,514
+4,319
| +2% | +$47.2K |
|
2354
Motorcar Parts of America
MPAA
$235M
| $2.5M | ﹤0.01% |
113,224
+2,636
| +2% | +$50.9K |
|
2355
Impinj
PI
$5.46B
| $2.49M | ﹤0.01% |
96,227
+7,385
| +8% | +$230K |
|
|
HCCI
2356
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $2.47M | ﹤0.01% |
78,640
+999
| +1% | +$28.6K |
|
|
YELL
2357
DELISTED
Yellow Corporation Common Stock
YELL
| $2.44M | ﹤0.01% |
955,656
+117,852
| +14% | +$404K |
|
2358
NN Inc
NNBR
$298M
| $2.44M | ﹤0.01% |
263,265
+6,972
| +3% | +$55.9K |
|
2359
Magnite
MGNI
$3.53B
| $2.43M | ﹤0.01% |
297,811
+11,519
| +4% | +$94.7K |
|
|
SILK
2360
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $2.43M | ﹤0.01% |
60,101
+10,006
| +20% | +$350K |
|
2361
AnaptysBio
ANAB
$1.66B
| $2.42M | ﹤0.01% |
149,185
+2,617
| +2% | +$61.9K |
|
2362
Precigen
PGEN
$2.32B
| $2.41M | ﹤0.01% |
440,479
+11,781
| +3% | +$66.3K |
|
2363
Quince Therapeutics
QNCX
$33M
| $2.41M | ﹤0.01% |
215
+92
| +75% | +$555K |
|
2364
Angi Inc
ANGI
$196M
| $2.4M | ﹤0.01% |
28,339
-515
| -2% | -$38.5K |
|
|
CNR
2365
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $2.4M | ﹤0.01% |
282,039
+9,814
| +4% | +$69K |
|
|
DX
2366
Dynex Capital
DX
$3.23B
| $2.39M | ﹤0.01% |
140,957
-8,806
| -6% | -$142K |
|
|
VRAY
2367
DELISTED
ViewRay, Inc.
VRAY
| $2.38M | ﹤0.01% |
564,027
+209,470
| +59% | +$677K |
|
|
LCI
2368
DELISTED
Lannett Company, Inc.
LCI
| $2.35M | ﹤0.01% |
66,704
+1,113
| +2% | +$45.3K |
|
|
PRMW
2369
DELISTED
Primo Water Corporation
PRMW
| $2.35M | ﹤0.01% |
208,872
+4,466
| +2% | +$49.5K |
|
2370
Accuray
ARAY
$32.9M
| $2.34M | ﹤0.01% |
830,223
-42,045
| -5% | -$117K |
|
2371
Calix
CALX
$2.51B
| $2.34M | ﹤0.01% |
292,170
+8,343
| +3% | +$62.2K |
|
|
MAXR
2372
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $2.33M | ﹤0.01% |
148,958
+3,548
| +2% | +$36.9K |
|
2373
Ducommun
DCO
$3.01B
| $2.33M | ﹤0.01% |
46,083
+20,546
| +80% | +$946K |
|
|
ODT
2374
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $2.3M | ﹤0.01% |
70,877
+1,736
| +3% | +$53.8K |
|
|
AMK
2375
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $2.3M | ﹤0.01% |
79,209
+1,672
| +2% | +$43.8K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.